1. Home
  2. SXC vs DBVT Comparison

SXC vs DBVT Comparison

Compare SXC & DBVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SunCoke Energy Inc.

SXC

SunCoke Energy Inc.

HOLD

Current Price

$9.71

Market Cap

801.2M

Sector

Industrials

ML Signal

HOLD

Logo DBV Technologies S.A.

DBVT

DBV Technologies S.A.

SELL

Current Price

$9.70

Market Cap

850.9M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
SXC
DBVT
Founded
1960
2002
Country
United States
France
Employees
848
90
Industry
Steel/Iron Ore
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
801.2M
850.9M
IPO Year
2011
2014

Fundamental Metrics

Financial Performance
Metric
SXC
DBVT
Price
$9.71
$9.70
Analyst Decision
Buy
Buy
Analyst Count
2
7
Target Price
$9.50
★ $38.55
AVG Volume (30 Days)
★ 897.5K
370.8K
Earning Date
10-27-2026
10-28-2026
Dividend Yield
★ 4.85%
N/A
EPS Growth
N/A
★ 10.26
EPS
★ 0.10
N/A
Revenue
★ $1,600,300,000.00
$5,636,000.00
Revenue This Year
$0.68
N/A
Revenue Next Year
N/A
$1,630.16
P/E Ratio
$98.35
★ N/A
Revenue Growth
10.30
★ 35.77
52 Week Low
$5.52
$8.63
52 Week High
$10.68
$26.19

Technical Indicators

Market Signals
Indicator
SXC
DBVT
Relative Strength Index (RSI) 45.89 37.63
Support Level $9.14 N/A
Resistance Level $9.79 $14.90
Average True Range (ATR) 0.28 0.46
MACD -0.03 0.10
Stochastic Oscillator 4.81 46.45

Price Performance

Historical Comparison
SXC
DBVT

About SXC SunCoke Energy Inc.

SunCoke Energy Inc operates as an independent producer of coke in the Americas. Its coke is mainly used as a principal raw material in the blast furnace steelmaking process as well as in the foundry production of casted iron. The company operates through two segments: Domestic Coke and Industrial Services. It offers metallurgical and thermal coal. The company also provides handling and/or mixing services to steel, coke, electric utility, coal-producing, and other manufacturing-based customers. The majority of revenue is derived from the Domestic Coke segment.

About DBVT DBV Technologies S.A.

DBV Technologies SA is a clinical-stage specialty biopharmaceutical company focused on changing the field of immunotherapy by developing a novel technology platform called Viaskin. The therapeutic approach is based on epicutaneous immunotherapy or EPIT, its proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin, an epicutaneous patch (i.e., a skin patch). Its main product candidate under development is Viaskin Peanut for the treatment of peanut-allergic patients. In addition, the company also has earlier-stage food allergy programs, including Viaskin Milk and Eosinophilic Esophagitis, or EoE.

Share on Social Networks: